BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCrown Bioscience Announces Collaboration to Develop Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) AntibodyBy Nasdaq OMXMay 8, 2017, 2:04 PM UTC
BusinessAvid Runner Creates 50+ Member Team to Support Ovarian Cancer After Battling the DiseaseBy Nasdaq OMXMay 5, 2017, 6:58 PM UTC
BusinessSelecta Biosciences Obtains License for Recombinant Immunotoxin LMB-100 from National Cancer Institute (NCI) for Pancreatic Cancer, Mesothelioma and Other CancersBy Nasdaq OMXMay 2, 2017, 12:00 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
BusinessTESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDABy Nasdaq OMXMay 1, 2017, 12:32 PM UTC
